PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 72 filers reported holding PASSAGE BIO INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $190 | -17.4% | 288 | +18.0% | 0.00% | – |
Q2 2023 | $230 | -55.0% | 244 | -54.3% | 0.00% | – |
Q1 2023 | $511 | +61.2% | 534 | +132.2% | 0.00% | – |
Q4 2022 | $317 | -68.3% | 230 | -63.1% | 0.00% | – |
Q3 2022 | $1,000 | -50.0% | 624 | -1.9% | 0.00% | – |
Q2 2022 | $2,000 | -80.0% | 636 | -80.2% | 0.00% | – |
Q1 2022 | $10,000 | -90.5% | 3,213 | -80.5% | 0.00% | – |
Q4 2021 | $105,000 | +1650.0% | 16,454 | +2584.2% | 0.00% | – |
Q3 2021 | $6,000 | 0.0% | 613 | +25.6% | 0.00% | – |
Q2 2021 | $6,000 | -68.4% | 488 | -53.9% | 0.00% | – |
Q1 2021 | $19,000 | -92.3% | 1,058 | -89.1% | 0.00% | – |
Q4 2020 | $248,000 | +376.9% | 9,724 | +144.9% | 0.00% | – |
Q3 2020 | $52,000 | -72.5% | 3,971 | -42.7% | 0.00% | – |
Q2 2020 | $189,000 | – | 6,929 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 2,497,922 | $63,872,000 | 14.76% |
FRAZIER MANAGEMENT LLC | 5,009,219 | $128,086,000 | 9.86% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 602,248 | $15,399,000 | 7.53% |
Vivo Capital, LLC | 1,487,038 | $38,024,000 | 1.70% |
Boxer Capital, LLC | 1,928,315 | $49,307,000 | 1.58% |
Orbimed Advisors | 6,962,899 | $178,041,000 | 1.56% |
Logos Global Management LP | 344,438 | $8,807,000 | 0.76% |
EMERALD ADVISERS, LLC | 340,698 | $8,712,000 | 0.29% |
Ikarian Capital, LLC | 136,697 | $3,495,000 | 0.15% |
Weiss Multi-Strategy Advisers LLC | 300,554 | $7,685,000 | 0.15% |